title: Comparison of drug-eluting balloon versus drug-eluting stent in patients with in-stent restenosis: insight from randomized controlled trials.
abstract: BACKGROUND
  In-stent restenosis (ISR) remains an important issue even in the current drug-eluting stent (DES) era. We performed a meta-analysis to assess the clinical efficacy and safety of drug-eluting balloon (DEB) as compared with DES for the treatment of ISR.
  
  
  METHODS
  The published literature was scanned by formal searches of electronic databases from January 2005 to February 2014. All randomized controlled trials were eligible for inclusion if they compared DEB with DES in patients with ISR.
  
  
  RESULTS
  Prespecified criteria were met by 4 trials involving 803 patients. There was no significant difference in the primary endpoint (12-month major adverse cardiac events) between the 2 groups (risk ratio [RR] 1.04, P=0.80). The incidence of death (RR 0.81, P=0.62), myocardial infarction (RR 0.66, P=0.29), and target lesion revascularization (RR 1.35, P=0.12) in the DEB group was also similar to those in the DES group.
  
  
  CONCLUSIONS
  This meta-analysis showed that DEB was associated with comparable clinical outcomes to DES for the treatment of ISR. DEB might be the preferred interventional strategy for patients with ISR by obviating the need of additional stent layer.
authors.affiliation: Department of Cardiology, Kashgar Prefecture Second People's Hospital, Kashi, Xinjiang 844000, China.
authors.forename: Wahafu
authors.initials: W
authors.lastname: Mamuti
authors.affiliation: Department of Cardiology, Kashgar Prefecture Second People's Hospital, Kashi, Xinjiang 844000, China.
authors.forename: Alimjan
authors.initials: A
authors.lastname: Ablimit
authors.affiliation: Department of Cardiology, Kashgar Prefecture Second People's Hospital, Kashi, Xinjiang 844000, China.
authors.forename: Wumaierjiang
authors.initials: W
authors.lastname: Kelimu
authors.affiliation: Department of Cardiology, Kashgar Prefecture Second People's Hospital, Kashi, Xinjiang 844000, China.
authors.forename: Fang
authors.initials: F
authors.lastname: Rao
authors.affiliation: Department of Cardiology, Kashgar Prefecture Second People's Hospital, Kashi, Xinjiang 844000, China.
authors.forename: Abulimiti
authors.initials: A
authors.lastname: Jiamali
authors.affiliation: Department of Cardiology, Kashgar Prefecture Second People's Hospital, Kashi, Xinjiang 844000, China.
authors.forename: Wei
authors.initials: W
authors.lastname: Zhang
authors.affiliation: Department of Cardiology, Kashgar Prefecture Second People's Hospital, Kashi, Xinjiang 844000, China.
authors.forename: Xiaoli
authors.initials: X
authors.lastname: Pei
authors.affiliation: Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai 200032, China. Electronic address: zhang.feng@zs-hospital.sh.cn.
authors.forename: Feng
authors.initials: F
authors.lastname: Zhang
mesh_terms: D015906:Angioplasty, Balloon, Coronary; D023903:Coronary Restenosis / Q000628:therapy*; D054855:Drug-Eluting Stents; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
keywords: Coronary artery disease; Drug-eluting balloon; Drug-eluting stent; In-stent restenosis